Regenique Group Limited (RGGG)
| Market Cap | 166.50M |
| Revenue (ttm) | 10.76M |
| Net Income (ttm) | 2.80M |
| Shares Out | 37.00M |
| EPS (ttm) | 0.08 |
| PE Ratio | 59.47 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About RGGG
Regenique Group is a customer-centric, science-backed aesthetics services provider. We prioritize delivering an unparalleled, premium experience for our customers by emphasizing safety, privacy and patient comfort. In addition to the market’s prevailing medi-aesthetics treatments, our suite of science-backed aesthetics services also includes bio-regenerative treatments and other advanced therapies. Our services are rendered through five strategically located clinics staffed by experienced doctors and equipped with advanced medical devices. Our ... [Read more]
News
Regenique Group Aims For $9 Million IPO On Slowing Growth
Regenique Group Limited seeks $9 million in a US IPO, offering bio-regenerative and medical aesthetic services in Singapore. RGGG shows slowing revenue growth, thin capitalization, and vague expansion...
Singaporean aesthetics procedures provider Regenique Group files and sets terms for $9 million US IPO
Regenique Group, which offers non-surgical aesthetic procedures in Singapore, filed on Friday with the SEC to raise up to $9 million in an initial public offering.
Regenique Group IPO Registration Document (F-1)
Regenique Group has filed to go public with an IPO on the NASDAQ